Doctors Without Borders supporters taking part in a demonstration calling for gamechanging HIV prevention drug Lenacapavir to be made more accessible and affordable to all.
Doctors Without Borders (MSF) is calling on governments in countries significantly affected by HIV/Aids to use legal instruments at their disposal to override the strict monopolistic patent conditions under which breakthrough HIV drug Lenacapavir is produced and traded around the world to broaden access and make it more affordable.
MSF launched a campaign last week calling on US-based pharmaceutical corporation Gilead Sciences to immediately make the highly effective HIV prevention medicine more accessible. MSF is asking governments to help expand access to Lenacapavir by using all available legal tools to challenge Gilead’s monopoly so other manufacturers can help boost the global supply and reduce its price.
The global humanitarian health organisation launched the campaign ahead of the United Nations General Assembly High-Level Meeting on HIV/Aids running from June 22-23 in New York.
The summit serves as the “primary global accountability mechanism for the HIV response”, aiming to review progress, address funding issues, and negotiate a new political declaration for the next five years, according to the UN’s website.
